(CNN Español) – The Oxford-AstraZeneca vaccine is in the wake of the hurricane’s lie that the European Medicines Agency concludes that it has a “cripple angle” between its application and the secondary effects caused by a combination of strange cases of bumps.
Although the AME does not readily recommend that its use be limited, the authorities of some countries, between the United Kingdom, have disagreed with it, for less than 30 years. Spain announces a similar medium and will only administer it to people between 60 and 69 years old.
It is true that the European regulator, like its British counterpart, has acknowledged that the evidence has reached an angle on the creation of blood coagulation. But the agencies have acknowledged that the possibilities of coagulation are very strong at the moment and that the AstraZeneca vaccine is very effective in preventing covid-19.
The EMA’s decision was based on 18 deaths in 62 cases of coagulation in the sinuses that drain the cerebrum and 24 cases of coagulation in the abdomen. The cases are being reported on a data base of the European Union, including the United Kingdom, where around 25 million people have been evacuated to the AstraZeneca pharmacy.
These are Latin American countries that have signed agreements to buy British-Swedish laboratory vacancies.
Argentina
Argentina has agreed to an agreement with Oxford / AstraZeneca in 2020 to buy 22 million doses of vaccine against the coronavirus, reports Reuters.
In addition, Argentina and Mexico have agreed with the University of Oxford, AstraZeneca and Argentine laboratories in Mexico to produce up to 400 million doses of vaccines against coronavirus. Argentina’s governor says it will cost between 3 and 4 dollars per dose, President Alberto Fernández announced in August 2020. These doses will be available to all Latin Americans, including Brazil, who have agreed to a proposal. These doses are available for all Latin Americans, including Brazil, which have a clear agreement.
“This agreement allows Latin America, and Argentina, in particular, to be able to accede between 6 and 12 months before the evacuation, at a time when no hubiéramos could have acquired it, so hubiéramos could unravel this agreement”, said Fernández, who aggregate that for Latin America the managers of the production chain seran Argentina and Mexico.
Bolivia
The Govierno of Bolivia announced on January 13 that it has signed a contract with AstraZeneca for 5 million doses of vaccines against the coronavirus.
Brazil
Brazil subscribes to receive 2 million doses of AstraZeneca vaccine. In January 2021, Brazil will authorize the emergency use of the Oxford / AstraZeneca and CoronaVac vehicles. The vacancies were imported from the Serum Institute by the Oswaldo Cruz Foundation of Brazil (Fiocruz).
Chile
During the third week of March, Chile has received a little over 13 million vacancies from Sinovac and Pfizer-BioNTech.
The Minister of Health, Enrique Paris, says that in addition to the vacancies of these companies, Chile has 875,000 doses of the Oxford / AstraZeneca vaccine.
“We will receive the map from Covax, from AstraZeneca to receive in the form of the program 875 miles approximately”, said Paris.
The Institute of Public Health of Chile announced on March 12 that AstraZeneca had requested information on “antecedents” from the vaccine against coronavirus following the announcement of the temporary suspension of the use of the vaccine against some of the countries of the European Union.
“Currently, there is no sufficient evidence to ensure that the thromboembolic events presented are associated with the administration of the vaccine, as it does not justify the adoption of any sanitary facility in our country,” said a statement from the Institute of Health. At this time, AstraZeneca’s vaccine requires the use of an emergency license, but does not require its import, distribution and use.
Colombia
In December 2020, the pharmaceutical company announced that it would enter into an agreement with the Colombian government for the summoner of 10 million doses of his vaccine against the coronavirus that would be used to vaccinate 5 million people.
Colombian President Iván Duque defends AstraZeneca’s vaccine on March 18 in support of the concepts that have been issued by the World Health Organization (OMS) and the European Medicines Agency (EMA), stating that the vaccine is safe and which does not constitute preoccupation with its application.
“In the meantime, what we have to say is based on this information, in addition, in our testimonials, that it is trustworthy and credible, that it secures the application of the AstraZeneca vaccine,” the Mandate said.
“For this reason, the message that we want to transmit is that there is currently no preoccupation with the application of this vacancy,” Duque added.
“AstraZeneca’s vacancies are safe and effective and we, as they enter the country, to proceed with their application with all security measures,” said Deputy Foreign Minister Salud Luis Alexander Moscoso to Duque.
Costa Rica
The company has agreed with AstraZeneca to acquire one million doses against covid-19 in order to benefit a million people. The vacancy involves an estimated cost of $ 4 per person, according to the Ministry of Health and the National Emergency Commission (CNE).
Ecuador
The pharmaceutical company announced an agreement with Ecuador to acquire more than 5.04 million doses of its vaccine against coronavirus, which will be enrolled in the first semester of 2021, according to a statement.
El Salvador
The National Directorate of Medicines of El Salvador approved in December the “import, distribution and use” of the vaccine against the covid-19 elaborada by AstraZeneca and the University of Oxford, confirming the authority of a journey of a communication to ‘ n final 2020.
At the moment, the health authorities of the country have not agreed on reasons to suspend the evacuation in a temporary manner, as there are many countries in Europe.
Guatemala
The country receives the first 81,600 doses of the Oxford / AstraZeneca vaccine through the Covax mechanism of the OMS, part of the 6.6 million doses that it hopes to receive the countries through this program, according to a March 11 statement of the Ministry of Public Health.
Honduras
Honduras has signed an agreement with AstraZeneca to raise 1.4 million doses, informs the Presidency of this country.
It has announced the suspension of the application of the Oxford / AstraZeneca vaccine in some European countries, the Honduras Sanitary Regulatory Agency on 11 March that the country will not receive AstraZeneca vaccines from lots that are being investigated in Europe. A security note published by the entity states that within the vacancies the country “will not be included including these lots”.
Mexico
Mexico has signed an agreement with AstraZeneca to obtain 30.8 million vacancies against the coronavirus as part of its plan to immunize 83 million Mexicans in 18 months.
Chancellor Marcelo Ebrard says the country has secured 18 million doses of the AstraZeneca vaccine that are in the final packing process to begin distribution to Mexico and other Latin American countries in April.
Ebrard says that “this is a great step for Latin America and the Caribbean; we can act together, we can resolve these important challenges and we can guarantee that our people have access to what they have right now ».
President Andrés Manuel López Obrador says these are vacancies against the covid-19 with the doses of the AstraZeneca vaccine. «No hay that tener miedo», dijo.
Panama
The Ministry of Health ensures that the company agrees to acquire 5.5 million doses of vacancies from AstraZeneca manufacturers, the Covax, Johnson & Johnson and Pfizer programs. It is hoped that there will be more than 1,000,000 AstraZeneca vacancies and other similar benefits from the same Covax work laboratory.
Paraguay
The country received on March 19 36,000 doses of AstraZeneca vacancies through Covax. According to a statement from the Panamericana Organization of Health, “In the coming weeks new vacancies will be carried out and it is hoped to complete the end of Mayo, the 304,800 doses” of this vacancy in Paraguay.
Peru
AstraZeneca signed an agreement with Peru to provide 14 million doses of the vaccine, according to a communication from the company. It is hoped that the country will reach the medians of 2021.
The Covax program covers 13.2 million doses. 117,000 from Pfizer and 400,000 from AstraZeneca in the first quarter of 2021, according to the governor of Peru.
The government informs that Peru has contracted companies for the vehicles of other laboratories such as Pfizer (20 million) and AstraZeneca (14 million) and Sinopharm, of which Peru consists of 38 million doses.
Dominican Republic
The company has agreed to receive 10 million doses of the AstraZeneca vaccine manufactured in India by the Serum Institute at Covishield. On February 15, the first 20,000 doses of these vacancies will be read.
President Luis Abinader says that the country consists of 10 million for AstraZeneca, 8 million for Pfizer and another 2 million for the Covax system. That is the sum of the 8 million vacancies reserved for Sinovac, which will be cleared in April and May, more than 768,000 from the same laboratory that the mandate signaled and the 2 million that will be cleared in March.
Uruguay
The country received the first 48,000 doses of the AstraZeneca / Oxford vaccine produced by SK Bioscience in Korea on April 4, 2021, informs OPS.
The country has agreed to acquire 3.75 million vacancies against covid-19 and aspire to vacate 2.8 million people, according to President Luis Lacalle.
Daniel Salinas, Minister of Health of Uruguay, dijo on his Twitter account which hopes that the National Assessment Commission for Vacancies will pass on its Independent criterion on the vacancy of AstraZeneca with regard to the observations of the European Regulatory Agency and the complications arising from the vacancy.
AstraZeneca is one of the first vacancies that the Assessors Commission has approved “for its safety and efficacy”, said Salinas.
“It is a vacancy approved by the Commission and registered with the MSP. We assure you that the current Commission has all the evidence to burn the maximum guarantees, “said the Minister of Health in his Twitter account.
Astra Zéneca. Vacancy approved by the WHO, the European Regulatory Agency EMA. It was one of the first vacancies to be approved for safety and efficiency. Calma.
– Daniel Salinas (@DrDanielSalinas) 2 April 2021